[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-374442-105":59,"doc-detail-374442-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerging-research-and-future-directions-on-doxorubicin-a-snapshot","Emerging Research and Future Directions on Doxorubicin - A Snapshot","","Doxorubicin is a widely used anthracycline antibiotic that has served as a foundation of cancer chemotherapy since the 1960s. Although effective for many malignancies, its clinical use is limited by cardiotoxicity and the emergence of drug resistance. Current research seeks a better therapeutic index through cardioprotective measures, non-invasive cardiac monitoring, nanoparticle/liposomal delivery, and prodrug or tumor-activated strategies. Combination concepts with immunotherapy, photodynamic therapy, and genetic modulation, alongside pharmacogenomics and predictive biomarkers, support more personalized regimens and improved patient outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-research-and-future-directions-on-doxorubicin-a-snapshot/374442/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-research-and-future-directions-on-doxorubicin-a-snapshot/374442.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is doxorubicin still important in cancer chemotherapy?","Question",{"text":112,"@type":113},"Doxorubicin is a cornerstone of oncology and is widely used because it is effective against a broad range of cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What main limitations hinder doxorubicin therapy?",{"text":117,"@type":113},"Key limitations include serious side effects, especially cardiotoxicity, and challenges posed by drug resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"How do current strategies aim to improve doxorubicin outcomes?",{"text":121,"@type":113},"Strategies include cardioprotective agents and non-invasive monitoring, advanced delivery systems (nanoparticles, liposomes, prodrugs), and combination approaches such as immunotherapy and photodynamic therapy, guided by biomarkers and pharmacogenomics.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},374442,1790245984,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Short Communications  \nEditorial Process: Submission:06/09/2024 Acceptance:01/21/2025  \nEmerging Research and Future Directions on Doxorubicin: A Snapshot  \nSaket Jitendre Sinha1, Bhupender Kumar2, Chandra Prakash Prasad3, Shyam Singh Chauhan4, Manish Kumar5 *  \nAbstract  \nDoxorubicin, a widely used anthracycline antibiotic, has been a cornerstone in cancer chemotherapy since the 1960s. In addition to doxorubicin, anthracycline chemotherapy medications include daunorubicin, idarubicin, and epirubicin. For many years, doxorubicin has been the chemotherapy drug of choice for treating a broad variety of cancers. Despite its efficacy, doxorubicin therapy is hindered by serious side effects, primarily cardiotoxicity, and the challenges of drug resistance. Recent research has focused on optimizing doxorubicin’s therapeutic index by developing cardioprotective strategies, such as dexrazoxane, and utilizing non-invasive monitoring techniques to reduce cardiac risk. To counteract drug resistance, innovative formulations like nanoparticle-based delivery systems, enhance targeted drug delivery and overcome cellular resistance mechanisms. Furthermore, using combination approaches involving immunotherapy, photodynamic therapy, and genetic modulation, offer promising synergies to maximize tumor eradication. Personalized approaches, supported by pharmacogenomics and predictive biomarkers, are enhancing individualized treatment regimens, aiming to increase effectiveness and minimize toxicity. Future research on doxorubicin focuses on developing advanced drug delivery systems, such as nanoparticle and liposomal formulations, to enhance targeted delivery, minimize systemic toxicity, and improve therapeutic precision. Efforts are also underway to design combination therapies that integrate doxorubicin with immunotherapies, photodynamic approaches, and gene-based treatments, aiming to overcome resistance and increase tumor-specific effects. These advancements signify a transition toward more personalized and effective doxorubicin-based cancer therapies, prioritizing reduced side effects and improved patient outcomes. This article focusses on the ongoing innovations aimed at maximizing the therapeutic potential of doxorubicin while addressing its limitations.  \nKeywords: Anthracycline-Doxorubicin-Cardiotoxicity-Drug Resistance-Cancers-Photodynamic therapy  \nAsian Pac J Cancer Prev, 26 (1), 5-15  \nIntroduction  \nDoxorubicin, a potent anthracycline antibiotic derived from Streptomyces peucetius, has been a cornerstone in oncology since its introduction in the 1960s. Alongside other anthracyclines such as daunorubicin, idarubicin, and epirubicin, it is widely utilized for the treatment of diverse malignancies, including breast cancer, lymphomas, and leukemias. Its mechanism of action primarily involves DNA intercalation and inhibition of topoisomerase II, leading to disruption of DNA replication and transcription in cancer cells. Apart from advantages, Doxorubicin (DOX) has limitations such as cardiotoxicity, drug resistance, limited efficacy in certain tumor types, and the risk of secondary malignancies. To address these limitations, researchers worldwide are  \nexploring novel approaches to maximize the therapeutic potential of doxorubicin and minimize its toxicity. This review highlights current advancements in doxorubicin research, with an emphasis on novel approaches aimed at overcoming its inherent limitations and optimizing its therapeutic potential in cancer management.  \nAn important area of research is the reduction of doxorubicin-induced cardiotoxicity. The use of cardioprotective agents and cardiotoxicity monitoring are the two approaches that are being probed to achieve this goal. Cardioprotective drugs, like dexrazoxane, can reduce cardiac injury without compromising the anticancer efficacy of doxorubicin. Enhanced imaging techniques and novel biomarkers can help in non-invasive monitoring of cardiac function, thereby enabling early dete","cbCaigAiVJG0hzgl","https://ap.wps.com/l/cbCaigAiVJG0hzgl","pdf",645792,11,"English","# Introduction\n## Reducing doxorubicin-induced cardiotoxicity\n## Reversing doxorubicin drug resistance\n## Innovative formulations and prodrug strategies","[{\"question\":\"Why is doxorubicin still important in cancer chemotherapy?\",\"answer\":\"Doxorubicin is a cornerstone of oncology and is widely used because it is effective against a broad range of cancers.\"},{\"question\":\"What main limitations hinder doxorubicin therapy?\",\"answer\":\"Key limitations include serious side effects, especially cardiotoxicity, and challenges posed by drug resistance.\"},{\"question\":\"How do current strategies aim to improve doxorubicin outcomes?\",\"answer\":\"Strategies include cardioprotective agents and non-invasive monitoring, advanced delivery systems (nanoparticles, liposomes, prodrugs), and combination approaches such as immunotherapy and photodynamic therapy, guided by biomarkers and pharmacogenomics.\"}]","Emerging Research and Future Directions on Doxorubicin - A Snapshot | PDF",1790201671,28]